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This review was conducted with the following goals: To quantify the severity of mood and anxiety 
symptoms emerging during acute abstinence from tobacco (1). To explore sex differences related to 
the experience of specific symptoms (2). To investigate the early time course of symptoms (3). 
A meta-analysis was performed from 28 studies assessing mood and anxiety symptoms during the 
earliest phases of tobacco abstinence (up to 24hrs post-quit) conducted from 1999 to 2019. Results 
revealed a significant (p<0.0001) increase in ‘anxiety’, ‘anger/irritability’, ‘depressed mood /sadness’, 
and composite negative affect (‘NA’) in the 24 hours following smoking cessation. The largest effect 
size was detected for ‘anxiety’ (0.63). A qualitative analysis was performed to investigate sex 
differences and the time course of the specific symptoms. Results indicated that female smokers may 
experience worse mood symptoms compared to male smokers and that these symptoms may emerge 
within 3hrs post-quit. Smoking cessation programs should implement sex-tailored interventions in 
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The World Health Organisation (WHO) describes tobacco smoking as “one of the biggest public health 
threats the world has ever faced” (WHO, 2019, p.1). Particularly, more than seven million individuals are 
reported to die each year because of tobacco induced and related diseases (WHO, 2019). 
According to the WHO (2019), more than 1.1 billion individuals worldwide are currently tobacco 
smokers. In the US alone, 26 million adults above 18 years old are reported to be daily smokers (Wang et 
al., 2018). Addiction to tobacco is caused by nicotine, a highly addictive psychostimulant drug present in 
tobacco products (WHO, 2019). Despite the majority of smokers having an intention to quit (Babb et al, 
2017), only 7% of smokers who attempt quitting remain abstinent (Babb et al, 2017). Research has 
estimated that “for many smokers it may take 30 or more quit attempts before being successful” (Chaiton 
et al., 2016, p.1), and that majority of relapses occur in the first few days following smoking cessation 
(Hughes, Kelly, & Naud, 2004 ; Zelle et al., 2017), with early lapses occurring several hours after 
quitting (Bolman et al., 2018; Brown et al., 2005;Deiches et al., 2013; Ferguson, Shiffman, & Blizzard, 
2017; Franklin et al., 2018). Notably, smoking lapses and relapses have been related to negative mood 
and anxiety symptoms emerging during acute abstinence from tobacco by a consistent body of research 
(Allen et al., 2008; Doherty et al.,1995; Hall et al., 2015; Minami et al., 2014; Patterson et al., 2008; 
Piper & Curtin, 2006; Piper et al., 2011; Shiffman, West, & Gilbert, 2004; Zvolensky et al., 2009). After 
a quit attempt, smokers may resume their smoking habit to alleviate these symptoms through ‘negative 
reinforcement’ (Baker et al., 2004; Koob & LeMoal, 2005). In the context of drug addiction, ‘negative 
reinforcement’ is defined as “the motivational basis of addictive drug use by the reduction or avoidance 
of internal aversive states” (Baker et al., 2004, p.34). According to this paradigm, an addicted individual 
perpetuates in drug use in order to relieve negative affective symptoms emerging during drug withdrawal 
(Koob & LeMoal, 2005). 
However, research conducted on young people and adolescents reported mild negative mood symptoms 
during abstinence from tobacco. Notably, these findings revealed that these symptoms may be less 




Abstinence from tobacco has been recently defined by Piper and colleagues (2019) as “abstinence from 
combustible tobacco products, smokeless tobacco products, and alternative products” (p.1). In the 
context of the current review, ‘acute abstinence’ refers to a time-period up to 24hrs since the last smoked 
cigarette and without utilizing any combustible or smokeless tobacco product, including alternative 
methods of nicotine administration (e.g. nicotine patches). Tobacco withdrawal symptoms such as 
negative mood (e.g. depressed mood, irritability) and anxiety may occur during this abstinence period 
(Hughes, 2007a).  
Under a neurobehavioral perspective, the emergence of negative mood symptoms during acute drug 
abstinence (including abstinence from tobacco) and the consequent motivational effect on relapse has 
been related to ‘opponent-process’ theories of addiction (Solomon and Corbit, 1974; Poulos and Cappell, 
1991). According to Solomon and Corbit (1974), the positive initial hedonic effect of a drug is 
counterbalanced by negative emotions that are caused by brain’s homeostatic regulation. This opponent- 
process strengthen as dependence develops, causing negative mood symptoms to emerge as soon as the 
drug is removed (Solomon and Corbit, 1974). Koob (2001) developed further this paradigm by proposing 
the opponent-process as a component of an allostatic state caused by a dysregulation of brain’s reward 
and stress systems that worsen progressively with the severity of drug dependence.  
Negative mood concepts such as ‘depressed mood’, ‘anxiety’, and ‘irritability’ are well established and 
listed in the DSM-V (American Psychiatric Association, 2013) as a component of the ‘Tobacco 
Withdrawal Syndrome’. Despite these guidelines, there is still uncertainty about the magnitude of the 
severity of specific mood symptoms experienced by smokers during acute abstinence from tobacco and 
to their early time course (Hughes, 2007a). DSM-V is limited in reporting that “the most commonly 
endorsed signs and symptoms are anxiety, irritability, and difficulty concentrating, while the least 
commonly endorsed symptoms are depression and insomnia”, and that “Tobacco withdrawal usually 
begins within 24 hours of stopping or cutting down on tobacco and peaks 2-3 days after abstinence” 
(American Psychiatric Association, 2013, p.576). However, several studies proposed that tobacco 
withdrawal symptoms may emerge as soon as 4 hrs post-quit (e.g. Hendricks et al., 2006). This has been 
further supported by recent neuroimaging findings that revealed disrupted neural processes in the 
mesocorticolimbic network following 4 hrs of smoking abstinence (Franklin et al., 2018).  
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Furthermore, little is known about possible sex differences related to the experience of specific mood 
symptoms. Data suggest lower long-term smoking abstinence rates for women compared to men, this 
regardless of treatments such as NRTs, Bupropion, nicotine patches, or counselling (Smith et al., 2015; 
Leventhal et al., 2007). Several studies investigated variables that could affect differentially smoking 
behavior and relapse in women compared to men, proposing attitudes towards cessation, social support 
during cessation, menstrual cycle, and nicotine reinforcement as possible as possible risk factors 
(Leventhal et al., 2007; Etter, Prokhorov, & Preneger, 2002; Borrelli et al., 2001; Craig, Parrot, & 
Coomber, 1992, Murray et al., 1995). However, it has been proposed that negative affective symptoms 
emerging during acute tobacco abstinence may strongly “mediate relationships between sex and smoking 
behavior, such as cessation” (Leventhal et al.,2007, p.22). In fact, recent studies (Becker, McLellan, & 
Reed, 2017; Smith et al., 2016) proposed that female smokers may suffer more severe withdrawal 
symptoms and that may relapse more frequently in comparison to male smokers. Therefore, the 
investigation of possible sex-differences related to mood and anxiety symptoms emerging during acute 
tobacco abstinence would be of particular importance as it may improve sex-tailored smoking cessation 
treatments, and it may help to reduce sex disparities in smoking cessation rates. 
No review, to our knowledge, has ever been conducted to quantify the severity of negative mood and 
anxiety symptoms emerging in the hours following smoking cessation, in addition to their early time 
course and to possible sex differences. Past reviews, such as those carried out by Taylor, McNeil, and 
Aveyard (2015) and by Lembke, Jhonson, and DeBattista (2007), focused on the decrease of negative 
affect symptoms during long-term abstinence (seven weeks to nine years), while other systematic reviews 
and meta-analyses focused on investigating the bi-directional relationship between smoking and 






Findings from a review conducted on this topic would enhance current guidelines (e.g. DSM-V) by 
providing a quantitative estimate of the severity of negative mood symptoms experienced by daily 
smokers in the hours following smoking cessation. Additionally, it would contribute significantly to the 
existing literature by validating the role of sex in relation to the experience of negative mood symptoms 
during acute tobacco abstinence, and by outlining the early time course of the same symptoms. 
A review was therefore conducted employing both meta-analytic and qualitative techniques with the 
following goals: 1) Provide a quantification of the severity of mood and anxiety symptoms emerging up 
to 24hrs during acute tobacco abstinence, 2) Investigate possible sex differences related to the 
experience of negative mood and anxiety symptoms emerging during acute tobacco abstinence, 3) 
Investigate the time course related to the manifestation of specific symptoms up to 24hrs during acute 








2.1 Search strategy 
 
Pubmed, Psychinfo, Ovid Embase, and Cochrane Controlled Trials registry databases were used to detect 
studies conducted between 01/01/1999 and  01/01/2019. Notably, this review wasn’t conducted to 
identify possible new symptoms occurring during acute tobacco abstinence.  It was instead conducted to 
assess the magnitude of change among existing mood symptoms, thus a limit of 20 years was applied to 
encompass studies assessing established negative mood and anxiety symptoms as described in DSM-IV 
and DSM-V (American psychiatric association, 1994; 2013). The inclusion/exclusion criteria listed in 
Table 1 below was used for both qualitative and quantitative parts of this review. 
8 
 
Table 1. Inclusion and exclusion criteria 
 
Inclusion criteria Exclusion criteria 
 
Studies employing a repeated-measures 
experimental design (ad. libitum smoking vs 
acute abstinence condition). 
Studies verifying tobacco abstinence through 
objective measurements. 
Studies testing human participants. 
 
Studies utilizing validated self-report 
measures of tobacco withdrawal, mood and 
anxiety* 
Studies measuring mood and anxiety 
symptoms at a single time point or at multiple 
time points during an acute tobacco abstinence 
period (up to 24hrs post smoking cessation) as 
reported by the tobacco withdrawal syndrome 
guidelines described in DSM-V **. 
Studies in all languages. 
 
Studies testing daily tobacco smokers. 
 
Studies testing participants from 15 to 60 
years old. 
Studies testing participants taking any 
medication/treatment to aid smoking cessation 
during the abstinence period. 
Studies testing participants enrolled in a 
smoking cessation treatment group/program or 
undergoing therapy/counselling to aid 
smoking cessation. 
Studies testing pregnant participants. 
 
Studies testing participants diagnosed with 
any co-morbid psychiatric disorder as 
described in DSM-V. 
Studies testing participants diagnosed with 
any substance use disorder (SUD) other than 
tobacco use disorder as described in DSM-V. 
Studies manipulating participants’ mood 
during tobacco abstinence (e.g. negative mood 
induction)- 
Studies testing participants taking any 
psychoactive medication. 
Studies testing smokers who relapsed during 
acute abstinence. 
 
Note. *: Validated self-report measures refer to psychometric scales with acceptable validity and reliability utilized to 
measure mood and anxiety symptoms of smokers during tobacco abstinence. The following scales were included 
(PANAS= Positive and Negative Affect Schedule; POMS=Profile of Mood States; MPSS=Mood and Physical Symptoms 




Withdrawal Scale; WSC=Withdrawal Symptoms Checklist; Diener and Emmons Mood form);**: Studies measuring 
mood and anxiety symptoms at multiple time points within a timeframe exceeding 24hrs were also included, although 
only those measurements taken up to 24hrs post smoking cessation were considered for the current review. DSM-V= 








Studies employing a within-subjects/repeated measures experimental design in which groups of smoker 
participants were tested at baseline during ad.libitum smoking (freely available smoking for pleasure) and 
subsequently at a time single time point or at multiple time points during an acute abstinence condition 
(up to 24hrs post-quit) were selected to be included in the review. Studies employing a mixed within- 
subjects and between-subjects design were also included. However, only within-group mood 
measurements (ad.libitum smoking vs acute tobacco abstinence) from smoker participants randomized to 
receive a placebo treatment or no treatment at all were included in the analyses. Cohorts of smoker 
participants receiving any form of treatment during abstinence (e.g. NRTs) other than placebo were not 
included in the study. 
The ‘Preferred Reporting Items for Systematic Review and Meta-Analysis’ (PRISMA) guidelines 
(Liberati et al., 2009) and the ‘Meta-Analysis for Observational Studies in Epidemiology’ (MOOSE) 
guidelines (Stroup et al., 2000) were utilised to aid the selection and subsequent assessment of the 
selected studies. The following search terms were used: (affective state* OR negative affect* OR mood 
OR emotion*OR negative valence) AND (nicotine OR smoking OR tobacco) AND (acute OR initial) AND 
(withdrawal OR abstinence OR cessation OR quit OR deprivation). The Research Domain Criteria 
(RDoC) matrix (Insel et al, 2010) was utilized to identify relevant units of analysis to insert as specific 
search terms in addition to the negative affective symptoms of ‘tobacco withdrawal’ listed in DSM-V 
(American Psychiatric Association, 2013). Both instruments were utilized as the RDoC Matrix does not 
contain a diagnostic tool for tobacco withdrawal. Therefore, the terms (affective state* OR negative 
affect* OR mood OR emotion*OR negative valence) were subsequently substituted with (anhedonia OR 
decreased appetitive behavior OR apathy), with (anxiety OR anxious arousal), with (depressed mood OR 





The current review utilized both quantitative and qualitative methods of data analysis. 
 
2.2.1 Data Extraction for Meta-Analysis 
The primary outcome of the current meta-analysis consisted in quantifying the effect of acute tobacco 
abstinence (up to 24 hrs post-quit) on mood and anxiety symptoms identified through the RDoC Matrix 
(Insel et al., 2010) and the DSM-V (American Psychiatric Association, 2013) in daily tobacco smokers 
(see supplementary Table 1a). The secondary outcome consisted in assessing the impact of relevant 
moderator variables such as severity of tobacco dependence, sex, age, and hours of tobacco abstinence on 
the same symptoms.  
It was possible to extract data to insert in the quantitative synthesis just for ‘depressed mood/sadness’, 
‘anxiety’, and ‘anger/irritability’ symptoms , as these were the negative mood and anxiety constructs 
measured more frequently through the psychometric scales employed by the studies included in the 
review. Total scores from negative affect (‘NA’) measures were also extracted. This allowed to conduct a 
sensitivity analysis assessing the impact of acute tobacco abstinence on the composite ‘NA’ construct, 
which encompasses the afore-mentioned symptoms (see Supplementary Table 1b). 
The Profile of Mood States (POMS) was the most utilized mood measure by the studies included in the 
meta-analysis (61%), followed by the Positive and Negative Affect Scale (PANAS) (22%), and by the 
Mood and Physical Symptom Scale (MPSS) (11%). The Wisconsin Smoking Withdrawal Scale (WSWS) 
was the least utilized measure (5%). All four scales measured the same outcome parameters such as 
‘depressed mood/sadness’, ‘anxiety’, and ‘anger/irritability’ through 5-point Likert scales with equivalent 
directions. They differed in wording used and in the total number of items. The PANAS, POMS, and 
WSWS also provided scores for total NA.  Particularly, the POMS (McNair, Lorr, & Droppleman, 
1971/1981) constitutes of a 65 items scale with three subscales “most consistent with the negative affect 
observed as part of nicotine withdrawal (i.e., tension–anxiety, depression–dejection, and anger–hostility)” 
(Heffner et al., 2011,p. 245). These are measured through a 5-point Likert scale ranging from ‘not at all’ 
(0) to ‘extremely’(4) . Similarly, the PANAS (Watson et al., 1988) consists of a 20 items scale measuring 
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positive and negative affect symptoms through a Likert scale ranging from ‘not at all’ (1) to ‘very much’ 
(5).  The MPSS (West & Hajek, 2004) was specifically developed to measure mood and anxiety 
symptoms emerging during tobacco withdrawal. It measures negative affect symptoms through seven 
items including symptoms of ‘anxiety’, ‘depressed mood’, and ‘irritability’. Scores are provided by rating 
a Likert scale ranging from ‘not at all’ (1) to ‘extremely’ (5). The WSWS (Welsch et al., 1999) is a 28 
items scale that “produces a total score as well as scores on seven subscales: anger, anxiety, 
concentration, craving, hunger, sadness, and sleep. Participants rate each item on a scale from strongly 
disagree (0) to strongly agree (4)” (Castro et al., 2011, p.548).  
Several studies compared the above mood and withdrawal measures revealing analogous psychometric 
properties. Particularly, a study conducted by West et al. (2006) revealed that both the MPPS and the 
WSWS showed high sensitivity in detecting changes in the ‘irritability’ construct during tobacco 
abstinence, with good reliability displayed for the other symptoms. Rossi and Pourtois (2006) conducted 
a systematic review comparing scales assessing rapid fluctuations in mood states such as POMS and 
PANAS. Their results showed that both POMS and PANAS provided “a reliable measure to capture rapid 
state-dependent variations in mood and anxiety” (Rossi & Pourtois, 2006, p.1) 
The data necessary to compute effect sizes estimating symptoms’ magnitude of change from baseline to 
acute tobacco abstinence consisted  in Means (M) and Standard Deviations (SD) for scores on the above 
mood measures performed at baseline (ad.libitum smoking) and in Means (M) and Standard Deviations 
(SD) for scores on the same mood measures performed at a single time point or at multiple time points 
during acute tobacco abstinence (up to 24hrs post-quit). Studies’ sample sizes and correlations between 
scores on mood measures performed at baseline and during abstinence were also required.  
All pooled studies reported M and SD for scores on mood measures performed at baseline and at a single 
time point during abstinence (within 24hrs post-quit). No raw data were reported. Only two studies 
reported M and SD for mood measurements performed at multiple time points post smoking cessation, 
thus hampering the possibility to investigate quantitatively the moderating effect of different time points 
on specific mood symptoms. These were further investigated qualitatively as described in section 2.2.4.  
Two studies reported M and SD for separate subgroups (males VS females) and not for the overall 
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sample. No study reported pre/post correlations. Therefore, the data extracted from the pooled studies 
consisted in Means (M) and Standard Deviations (SD) for scores on mood measures performed at 
baseline (ad.libitum smoking) and at a later single time point during acute tobacco abstinence (within 
24hrs post-quit) by daily tobacco smokers.  
Moderator variables such as severity of tobacco dependence (‘dependence’), ‘sex’, hours of abstinence 
(‘hours’), and ‘age’ were also extracted from the pooled studies. The ‘dependence’ moderator consisted 
in numerical scores on subjective measures of tobacco dependence (e.g. FTND, HONC). The ‘sex’ 
moderator consisted in percentage of female and male smokers in each study sample. These variables 
were transformed prior to be included in the software as subsequently described in section 2.2.2. 
 
2.2.2 Meta-Analysis  
Meta-analytic calculations were performed using the Meta-Analysis Version III software (Borenstein et 
al., 2013). A random-effect model was preferred over a fixed-effect model to address plausible effect size 
variations between studies. The selected data entry format consisted in ‘One group (Pre-post) data’ 
(Borenstein et al., 2013). A Standardized Mean Difference (SMD) effect size was selected as a statistical 
summary measure because the studies employed different psychological rating scales to assess the same 
mood and anxiety symptoms. The significance threshold was set at p<0.05 to reflect the 95% of 
probabilities of rejecting the null hypothesis (Cohen, 1988). Cohen’s d (Cohen, 1988) was utilized as a 
benchmark-criteria for effect sizes to assess the magnitude of the impact of acute tobacco abstinence on 
mood and anxiety symptoms. Specifically, an effect size of 0.2 would have implied a ‘small’ effect size, 
an effect size of 0.5 would have implied a ‘medium’ effect size, and an effect size of 0.8 would have 
implied a ‘large’ effect size (Cohen, 1988). 
Calculations were performed to obtain combined group values for two studies reporting means and 
standard deviations only for separate subgroups (e.g. males vs females) and not for the overall sample. 





N1M1 + N2M2 
N1 + N2 
 




N1= sample size of group1 
N2= sample size of group2 
M1= mean value of group1 
M2= mean value of group2 
 




SD1= standard deviation value of group1 
SD2= standard deviation value of group2 
Missing pre and post correlations were imputed at a value of 0.5. According to Fu et al. (2013), Balk et al 
(2012), and to Follman et al. (1992), imputing within-group correlation values at 0.5 does not introduce 
bias in the summary estimate of the treatment effect. Confirming this, sensitivity analyses assuming 
correlation values of 0 and 0.9 were carried out to corroborate the robustness of the analyses (Borenstein 
et al.,2009; Follman et al., 1992). Two sensitivity analyses were conducted for each mood construct 
(‘anxiety’, ‘depressed mood/sadness’, ‘anger/irritability’, and total ‘NA’) in order to estimate symptoms’ 
magnitude of change from baseline (ad.libitum smoking) to acute tobacco abstinence (up to 24hrs post-
quit). A random effect model was employed. The same data (M, SD, samples size) utilized to compute 
effect sizes with a pre/post correlation of 0.5 were inserted in the software. Analyses were conducted by 
substituting pre/post correlations of 0.5 with 0 and subsequently with 0.9, revealing no significant 
changes between effect size estimates. These results are described subsequently in section 3.1.6. 
(SD12 + SD22)/2 
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The ’dependence’ moderator was computed by converting the extracted numerical scores on subjective 
measures of tobacco dependence (e.g. FTND, HONC) reported in each study into categorical levels of 
dependence (e.g. ‘low’, ‘medium, ‘high’) according to the scoring guidelines of the respective 
instruments. This allowed additional subgroup analyses for each level of dependence and to display the 
results in forest plots. Regarding sex, percentages of female and male participants in each study sample 
were converted into decimal data and inserted as covariates in the software. The extracted data related to 
‘hours’ and ‘age’ were also inserted as covariates. 
Meta regressions were therefore conducted to assess the impact of each moderator variable on mood and 
anxiety symptoms emerging during acute tobacco abstinence. Particularly, four meta-regressions were 
conducted for each mood and anxiety symptom in addition to negative affect. This allowed to assess the 
possible impact of severity of tobacco dependence (‘dependence’), ‘sex’, hours of abstinence (‘hours’), 
and ‘age’ on each construct.  Additionally, a multiple regression model was computed in order to assess 




2.2.3 Publication bias 
 
Publication bias was assessed using Funnel Plot analyses and Fail-Safe N tests (Rosenthal, 1979). Funnel 
plots for each construct were visually inspected to exclude presence of bias (see supplementary figures 
13-16). Additionally, Egger’s regression test (Egger et al., 1997) was carried out in order to address 
possible subjective misinterpretation of funnel plots’ asymmetry that may occur when there are few 
studies included in the meta-analysis (Simmonds, 2015). Fail safe N and Egger’s tests results are 










2.2.4 Qualitative analysis 
 
Additionally, a ‘narrative synthesis’ methodology (Dixon-Woods et al., 2005) was employed to 
summarize the findings of studies investigating sex differences related to the experience of negative 
mood symptoms during acute abstinence from tobacco, and of studies investigating the early time 
course of symptoms. In particular, two reviewers (AAC and AB) identified and pooled key results 
from each study and provided a descriptive summary of the findings. The summarized evidence was 
subsequently interpreted and a preliminary conclusion for the effect of sex on mood symptoms and on 




2.2.5 Assessment of study quality 
 
The quality of the studies included in the review was assessed using the ‘Quality Assessment Tool for 
Before-After (Pre-Post) Studies With No Control Group’ (Study Quality Assessment Tools, 2017) and 
for studies employing a within-subjects experimental design the ‘ Quality Assessment for Observational 
Cohort Studies’ (Study Quality Assessment Tools, 2017) for studies employing a mixed within-subjects 
and between-subjects experimental design. For both assessment tools, a ‘good’ study would have 
indicated a study presenting low risk of bias, a ‘fair’ study would have indicated a study presenting a 
moderate risk of bias but not sufficient to invalidate the results, and a ‘poor’ study would have indicated 
a study presenting high risk of bias, in addition to serious methodological flaws (Study Quality 
Assessment Tools, 2017).  
Two reviewers (AAC and AB) assessed the internal and external validity of each study utilizing the 
afore-mentioned tools. Consensus was reached through discussion in case of a discordant opinion 









Of these 3529 identified studies, 1373 were duplicates and therefore excluded. Two thousand one 
hundred and fifty-six studies were subsequently inspected through title and abstract reading, leaving a 
total of 573 studies eligible for inclusion in the review. Once these papers were accessed a further 545 
studies were excluded (see Figure 1 below). In total, 28 studies were included in this review. However, 
it was not possible to include all 28 studies in the quantitative synthesis. In fact, only two studies (Pang 
& Leventhal, 2013; Xu et al., 2008) reported means and standard deviations for scores on mood 
measures for both male and female subgroups, thus hampering the possibility of computing effect sizes 
for males vs females during acute tobacco abstinence. Similarly, two studies (Aguirre et al., 2015; 
Morrel et al., 2008) measured negative mood and anxiety symptoms at multiple time points within a 
24hrs abstinence timeframe and reported means and standard deviations for each time point. Thus, 
studies investigating sex differences and the early time course of symptoms were inserted in the 
qualitative synthesis. In particular, 18 studies were included in the quantitative synthesis (Bello et al., 
2016; Bidwell et al., 2013; Colby et al., 2010; Cook et al., 2004; Everson et al., 2006; Froeliger et al. 
2015; Hendricks & Leventhal, 2013; Leventhal et al., 2010, 2013, 2014 ; Park et al., 2016; Quinn et 
al., 2014; West & Hajeck, 2004; Wong et al, 2014) , while 14 were included in the qualitative 
synthesis (Al Absi et al., 2002; Ashare & Kable, 2015; Brown et al., 2013; Bujarski et al., 2015; 
Hendricks et al., 2006; Jacobsen et al., 2005; Leventhal et al., 2007; Perkins et al., 2013; Sheets et al., 
2015;Smith et al., 2009). Four studies (Aguirre et al., 2015; Morrel et al. 2008; Pang & Leventhal, 
2013; Xu et al., 2008) were included in both quantitative and qualitative syntheses as they presented 
data valid for both types of analyses. 
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Figure 1. Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) 
1999-2019; *: Four studies were included in both quantitative and qualitative analyses 
Records identified through 
database searching 
(n=3529) 




Total studies included 
in the review 
(n=28) 
Records excluded 
through title and 
abstract reading 
(n=1583) 
Records after duplicates 
removed and screened 
(n=2156) 
 
Studies included in the 
qualitative synthesis 
(n=14)* 
Full-text articles excluded, 
with reasons (n = 545) 
 




-smokers affected by co- 
morbid psychiatric disorder 
(n= 34) 
-smokers affected by 
polydrug dependence 
(n=66) 
- studies employed 
between-subjects 
experimental design only 
(n=43) 
- no objective measurement 
of smoking cessation (n= 16) 
- smokers enrolled in 
smoking cessation 
programs/treatments (n=74) 
-pregnant smokers (n=17) 
 
-non-daily smokers (n=23) 
 
- mood measurements taken 














Of the 18 studies included in the meta-analysis, 12 were classified as ‘good’ and six were classified as 
‘fair’ according to the assessments of study quality listed in section 2.2.4. Fourteen studies employed a 
within-subjects experimental design, while the remaining four studies employed a mixed within-subjects 
and between-subjects experimental design. The mean hours of tobacco abstinence at which mood 
measurements were performed for the 18 pooled studies was 17 hrs (SD=3.63), while the median was 
16hrs. The lowest time point at which mood measurements were performed consisted in 12hrs, the 
highest in 24hrs. All participants included in the analyses were abstinent during the acute abstinence 
condition as biochemically verified in each study (e.g. exhaled CO, salivary cotinine). Participants who 
failed to maintain abstinence were either excluded from the studies or rescheduled to another 
experimental session.  






Table 2. Characteristics of studies assessing the impact of acute tobacco abstinence on mood and anxiety symptoms included in the meta-analysis. 
 
 
Study Study Intention Time points Mood measures Objective Level of Tobacco Years of Mean Sample size Age in Study Design 
(Countr Quality to quit for mood and  measure of acute Dependence regular cigarettes and sex years  





 smoking (SD) smoked per 
day (SD) 
(%) (SD)  
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17.0* 
























al 2016     Monoxide (CO) 5.4 24.9 16.8 females, 67.6% (10.6) experimental 
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Salivary Cotinine 
4.5 (N/A) (N/A) females, 39% 
males) 








Colby et Good No 15.0 PANAS Breath Carbon SDI   31 (58 % 15.6 Mixed between- 
al, 2010 
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Everson Fair No 17.0 MPSS Breath Carbon HONC N/A 13.8 19 (53% 17.8 Mixed within- 
et al,     Monoxide (CO) 7  (3.72) females, 47.3% (0.92) subjects and 
2006         males)  between-subjects 
(UK)           experimental 











    Monoxide (CO) 6.4 (8.0) (7.2) females, 62% 
males) 







































Leventha Good No 16.0 POMS Breath Carbon FTND   275 (69% 44.2 Within- subjects 
l et al     Monoxide (CO) 5.2 24.8 16.7 males, 31% (10.6) experimental 
2014 
(USA) 
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al. 2016     Monoxide (CO) 5.2  16.7 (68% males, (11.06) experimental 




Quinn et Good No 16.0 POMS Breath Carbon FTND 24.2  153 (66.0%  within-subjects 
al 2014     Monoxide (CO) 5.3 (N/A) 16.8 males, 43.7 experimental 




















96 (41% males, 
  
Within- subjects 
Hajek     Monoxide (CO)   (8.70) 59% females) 39.8 experimental 
2004 
(UK) 

























    Monoxide (CO) 6.7  21.7 
(N/A) 
78% females) (N/A) experimental 
design 
 






























Note*:It was only possible to insert in the meta-analysis one time point measurement for studies assessing mood and anxiety symptoms at multiple time points. For this reason, these studies were also 
included in the qualitative synthesis. **: Demographic characteristics and number of participants for nonsmoker controls or groups receiving a treatment other than placebo or no treatment at all that 
were reported in studies employing a mixed between-subjects and within-subjects experimental design were not included in the table as they were not considered for the current review. FTND= 
Fagerström Test of Nicotine Dependence (severity score: 0-2: Very low dependence, 3-4: Low dependence, 5: Medium dependence, 6-7:High dependence, 8-10: Very high Dependence); 
HONC=Hooked on Nicotine Checklist(severity score: 0 low to 10 very high); PANAS= Positive and Negative Affect Schedule ; POMS=Profile of Mood States ; MPSS=Mood and Physical 






No statistically significant asymmetry was detected for each mood and anxiety symptom 
by inspecting Egger’s regression tests (p>0.05). Fails-Safe N tests results revealed that a 
large number of non- statistically significant studies would have been needed to nullify 
the effect of acute tobacco abstinence on each symptom, therefore indicating the absence 
of publication bias in the current meta-analysis (Table 3). The assumption of 
homogeneity was not met for each mood and anxiety symptom as reported by Q and I2 
tests (Table 3), thus justifying the application of a random effects model for the meta- 
analysis. 
Forty-five effect size measurements were computed: 10 for ‘anxiety’, 11 for 
‘anger/irritability’, 12 for ‘depressed mood/sadness’, and 12 for composite negative 
affect (‘NA’). These are summarized in Table 3 below. Another 45 effect size 
measurements were computed by running separate analyses for each level of tobacco 
dependence for all mood and anxiety symptoms. Ninety effect sizes are reported in 
Supplementary Figures 1-8. Meta regressions testing the impact of each moderator on 









Table 3. Pooled effect sizes for the severity of mood and anxiety symptoms experienced by daily smokers during acute abstinence from tobacco. 
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Q11 
 














1=Number of daily smokers ;2=Number of pooled studies; 3= Mean hours of tobacco abstinence at which mood measurements were taken;4=Cohen’s d effect 
size;5=Standard error; 6= Lower limit of the 95% confidence interval for the effect size; 7= Upper limit of the 95% confidence interval for the effect size; 8= 
One sample Z Statistic; 9= Probability that Z Statistics is significantly different than 0; 10= Q statistic; 11= Probability that Q statistics significantly different 
than 0; 12= I2 statistic; 13= Classic Fail safe N; 14=Probability that Egger’s test is significantly different than 0. 
10 15.5 0.63 0.06 0.50 0.77 9.2 0.00 45.1 0.00 80.06 1061 0.34 
11 16.1 0.51 0.06 0.38 0.64 7.6 0.00 54.2 0.00 81.5 829 0.24 































For ‘anxiety’, a significant effect size (p<0.0001) was detected for the acute tobacco abstinence condition 
in comparison to the ad.libitum smoking condition (see Table 3 above and Supplementary Figure 1). 
Subgroup analyses revealed a major impact of acute abstinence from tobacco on ‘anxiety’ for studies 
reporting a ‘high’ level of tobacco dependence (SMD=1.016, Z=13.805, p<0.0001) in comparison to 
studies reporting a ‘medium’ level of dependence (SMD=0.519, Z=15.923, p<0.0001), and in comparison 
to the study reporting a ‘low’ level of dependence (SMD=0.671, Z=3.322, p=0.001) for the respective 
samples (see Supplementary Figure 2). 
3.1.2 Anger/irritability 
 
For ‘anger/irritability’, a significant (p<0.0001) and medium effect size was detected for the acute tobacco 
abstinence condition in comparison to the ad.libitum smoking condition (See Table 3 above and 
Supplementary Figure 3). Subgroup analyses revealed a major impact of acute abstinence from tobacco 
on ‘anger/irritability’ for studies reporting a ‘high’ level of tobacco dependence (SMD=0.712, Z=4.453, 
p<0.0001) in comparison to studies reporting a ‘medium’ level of dependence (SMD=0.379, Z=11.643, 
p<0.0001) (see Supplementary Figure 4). 
3.1.3 Depressed mood/sadness 
 
For ‘depressed mood/sadness’, a significant (p<0.0001) and small effect size was detected for the acute 
tobacco abstinence condition in comparison to the ad.libitum smoking condition (see Table 3 above and 
Supplementary Figure 5). Subgroup analyses revealed a major impact of acute abstinence from tobacco on 
‘depressed mood/sadness’ for studies reporting a ‘high’ level of tobacco dependence (SMD=0.603, 
Z=9.246 , p<0.0001) in comparison to studies reporting a ‘medium’ level of dependence (SMD=0.166, 
Z=5.557, p<0.0001), and in comparison to the study reporting a ‘low’ level of dependence (SMD=0.135 , 
Z=0.735 , p=0.462) (see Supplementary Figure 6). 
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3.1.4 Composite Negative Affect (‘NA’) 
 
For composite ‘NA’, a significant (p<0.0001) and medium effect size was detected for the acute tobacco 
abstinence condition in comparison to the ad.libitum smoking condition (see Table 3 above and 
Supplementary Figure 7). Subgroup analyses revealed a major impact of acute abstinence from tobacco on 
composite ‘NA’ for studies reporting a ‘high’ level of tobacco dependence (SMD=1.005 , Z=8.702, 
p<0.0001) in comparison to studies reporting a ‘medium’ level of dependence (SMD=0.277 , Z=9.452 , 
p<0.0001), and in comparison to the study reporting a ‘low’ level of dependence (SMD=0.368 , Z=2.442 , 






A significant effect was detected for sex on ‘anxiety’ (slope Z=2.94, p=0.003), on ‘anger/irritability’ 
(slope Z=4.52, p<0.0001), on ‘depressed mood/sadness’ (slope Z=2.84, p=0.004), and on composite ‘NA’ 
(slope Z=4.35, p<0.0001), with samples consisting of a higher percentage of female smokers reporting 
more severe mood and anxiety symptoms in comparison to samples with a smaller percentage of female 
smokers (see supplementary Figures 9-12). The effect of sex remained significant (p<0.05) on ‘anxiety’ 
and ‘anger/irritability’ after controlling for levels of tobacco dependence, hours of abstinence, and age in 
a meta-regression model as illustrated in supplementary Table 2. No effect for ‘age’ was detected 
(P>0.05). The same regression model revealed a possible effect for hours of abstinence on ‘anxiety’ 
(p<0.05) and on ‘anger /irritability’ (p=0.001) symptoms while holding constant the other moderator 
variables (see supplementary Table 2). Symptoms of ‘anxiety’ and of ‘anger/irritability’ were most severe 
at 12hrs post-quit in comparison to the other time points, suggesting a possible earlier peak in comparison 
to symptoms of ‘depressed mood/sadness’. 
A significant effect was detected for levels of tobacco dependence on all mood and anxiety symptoms 





3.1.6         Sensitivity analysis 
Sensitivity analyses conducted with pre/post correlation values of 0 detected a significant effect for the acute 
tobacco abstinence condition  in comparison to the ad.libitum smoking condition on ‘anxiety’, (SMD=0.639, 
p<0.0001), ‘anger/irritability’ (SMD=0.522, p<0.0001), ‘depressed mood/sadness’ (SMD=0.272, p<0.0001), 
and total ‘NA’ (SMD=0.479, p<0.0001). Similarly, sensitivity analyses conducted with a pre/post correlation 
value of 0.9 revealed a significant effect for the acute tobacco abstinence condition  in comparison to the 
ad.libitum smoking condition on ‘anxiety’, (SMD=0.569, p<0.0001), ‘anger/irritability’ (SMD=0.451, 
p<0.0001), ‘depressed mood/sadness’ (SMD=0.261, p<0.0001), and total ‘NA’ (SMD=0.396, p<0.0001) 




A total of 14 studies were included in the qualitative review. Seven of these studies assessed sex 
differences related to negative mood and anxiety symptoms experienced during acute tobacco 
abstinence (Al’Absi et al, 2002; Ashare & Kable, 2015; Jacobsen et al, 2005; Levental et al, 2007; 
Perkins et al, 2013; Pang & Leventhal, 2013; Xu et al, 2008), while another seven studies assessed 
the impact of acute tobacco abstinence on negative mood and anxiety symptoms at multiple time 
points within a 24hrs timeframe (Aguirre et al, 2015; Brown et al, 2013; Bujarski et al, 2015; 
Hendricks et al, 2006; Morrel et al, 2008; Sheets et al, 2015; Smith et al, 2009). Study characteristics 





Table 4a. Characteristics of studies assessing sex differences related to the experience of negative mood and anxiety symptoms during acute 
tobacco abstinence. 
 
Study Study Intention Time Mood Objective Level of Years of Mean Sample size Age in Study Design 
(Countr) Quality to quit points for measures measure of acute Tobacco regular cigarettes and sex years  
  mood and  tobacco Dependence smoking smoked per (%) (SD)  
  anxiety  abstinence  (SD) day (SD)    
  measurem         
  ents in         






Ashare & Good No 24.0 PANAS Breath Carbon FTND N/A 16.4 33 (63% males, 38.5 Within- subjects 
Kable,     Monoxide (CO) 4.7(1.6)  (11) 37% females) (13.8) experimental design 
















































    Monoxide (CO) 
Urinary Cotinine 
2.6 (N/A) (6.7) females, 35% 
males) 




Leventha Good No 12.0 PANAS Breath Carbon FTND 19.7 22.2 203 (50% 36.7 Within- subjects 
l et al. 
2007 
(USA) 
    Monoxide (CO) 6.47 (10.3) (6.61) males, 50% 
females) 










Pang & Good No 16.0 POMS Breath Carbon FTND   199 43.4 Within-subjects 
Leventha     Monoxide (CO) 5.3 24.2 16.7 (66% males, (10.2) experimental 
l 2013 
(USA) 




























   Emmons 
(1984) 
Mood Form 






























    Monoxide (CO) 5.2 (N/A) (N/A) 41% females) (N/A) experimental design 
 
 
Note. **: Demographic characteristics and number of participants for nonsmoker controls or groups receiving a treatment other than placebo or no treatment at all that were 
reported in studies employing a mixed between-subjects and within-subjects experimental design were not included in the table as they were not considered for the current review. 
CO= Carbon Monoxide; FTND= Fagerström Test of Nicotine Dependence (with severity score: 0-2: Very low dependence, 3-4: Low dependence, 5: Medium dependence, 6-7: 
High dependence, 8-10: Very high Dependence); hrs= hours; PANAS= Positive and Negative Affect Schedule; POMS=Profile of Mood States;;WSC=Withdrawal Symptoms 




Table 4b. Characteristics of studies assessing the early time course of mood and anxiety symptoms during acute tobacco abstinence. 
 
Study Study Intention Time Mood Objective Level of Years of Mean Sample size Age (SD) Study Design 
(Countr Quality To quit points for measures measure of acute Tobacco regular cigarettes and sex   











(%)   




  17.0 POMS Monoxide (CO) 5.3 (N/A) (7.0) males, 32% 
females) 
























Mixed within subject 
al, 2013   2.0  Monoxide (CO)  (N/A) (N/A) (51.5% (N/A) and between- 
(UK)   4.0      females, 49.5%  subjects experimental 
   6.0      males)  design** 
 
 
Bujarski Fair No Hourly EMA Breath Carbon FTND N/A Moderate 30 (30% Moderate Mixed within- 
et al   during a measure Monoxide (CO) Moderate  smokers: females,70% smokers: subject and between - 
2015   24hrs items taken Urinary cotinine smokers:  9.5 (2.4) males) 36.7(11.7) subjects experimental 
(USA)   period from 
POMS 





    And  Heavy smokers:  19.1 (2.7)  38.3  





















s et al.   1.0  Monoxide (CO) 5.4 12.8 23.5 females, 42% (8.3) experimental design 
2006   1.5  Heart Rate (HR)  (8.1) (4.7) males)   
(USA)   2.0         
   2.5         
   3.0         
   3.5         
   4.0.         
Morrel et Fair No 3.5 POMS Breath Carbon FTND N/A 16.0 30(74% males, 27.0 within -subjects 
al.2008 
(USA) 




Sheets et Fair No Hourly EMA Breath Carbon FTND N/A Moderate 30 (30% Moderate Mixed within- 
al., 2015   during a measure Monoxide (CO) Moderate  smokers:9.5 females, 70% smokers: subjects and 
(USA)   24hrs items taken Urinary cotinine smokers:  (2.4) males) 36.7 between- subjects 
   period from 
POMS and 



































al. 2009   3.5 POMS Monoxide (CO) 4.0 (N/A) (N/A) (49% females, (1.3) subjects and within- 
(USA)   14.5  Salivary Cotinine    51% males)  subjects 
   17.5        experimental 
   20.0        design** 
   22.5         
 
 
Note. **: Demographic characteristics and number of participants for nonsmoker controls or groups receiving a treatment other than placebo or no treatment at all that were 
reported in studies employing a mixed between-subjects and within-subjects experimental design were not included in the table as they were not considered for the current review. 
CO= Carbon Monoxide; FTND= Fagerström Test of Nicotine Dependence ( with severity score: 0-2: Very low dependence, 3-4: Low dependence, 5: Medium dependence, 6-7: 
High dependence, 8-10: Very high Dependence); hrs= hours; MNWS=Minnesota Nicotine Withdrawal Scale; POMS=Profile of Mood States; MPSS=Mood and Physical 





3.2.1 Sex differences 
Overall, five of the seven studies revealed significant differences between female and male 
smokers. 
The study conducted by Pang and Leventhal (2013) revealed that female smokers suffered more 
severe abstinence-induced effects on negative affect constructs such as ‘anger’, ‘anxiety’, 
‘depression’ and composite ‘NA’ in comparison to male smokers. After applying a Bonferroni- 
Holm correction for type 1 error, these authors revealed that sex differences remained significant 
for the ‘anxiety’ and composite ‘NA’ constructs. Similar findings were reported in the study 
conducted by Xu et al. (2008) in which female smokers experienced worse anger and anxiety 
symptoms during acute abstinence from tobacco (13hrs) in comparison to male smokers. The 
study conducted by Al’Absi et al. (2002) reported higher anxiety and irritability 18hrs after 
smoking cessation in comparison to male smokers. 
Leventhal et al. (2007) conducted a study to specifically investigate sex differences on objective 
(physiological) and subjective (affective) measures of tobacco withdrawal during an acute 
abstinence period of 12hrs. According to their findings “women consistently reported larger 
abstinence-induced increases in negative affect (i.e., anger, anxiety, sadness, irritability, tension, 
restlessness, impatience) and greater desire to relieve withdrawal distress by smoking than 
men”(73, p.1). Jacobsen et al. (2005) showed that symptoms of ‘anxiety’ increased significantly 
just for adolescent female smokers during a 24hrs abstinence period. However, studies conducted 
by Perkins et al. (2013) and by Ashare & Kable (2015) did not reveal any main effect of sex on 







Considering that these studies utilized an analogous experimental design, it can be inferred that 
female smokers may experience more severe mood and anxiety symptoms in comparison to male 
smokers (with similar levels of tobacco dependence) up to 24 hrs post smoking cessation. This 
may be especially relevant for ‘anger/irritability’, and ‘anxiety’ symptoms as reported by the 
aforementioned studies (Al’Absi et al., 2002; Jacobsen et al., 2005; Leventhal et al., 2007; Xu et 
al. 2008). These findings provide support to the meta-regression results as described in section 
3.1.5. 
3.2.2 Time course 
 
Studies that explored the time course of negative mood and anxiety symptoms up to 24hrs post 
smoking cessation (Aguirre et al., 2015; Brown et al., 2013; Bujarski et al., 2015; Hendricks et al., 
2006; Morrel et al., 2008 ; Sheets et al., 2015; Smith et al., 2008) revealed that symptoms 
manifested during acute abstinence (as soon as 1hr post-quit) and that their severity increased as 
the length of the abstinence period increased. 
In particular, Hendricks et al. (2006) revealed that ‘anger’ symptoms manifested significantly at 1 
hr post-smoking cessation, followed by ‘anxiety’ (2hrs) and ‘sadness’ (3hrs) symptoms in a 
sample of 50 daily smokers. Similarly, a study conducted by Morrel et al. (2008) on 30 daily 
smokers with a medium level of tobacco dependence showed that symptoms of ‘anxiety’ 
manifested significantly (p<0.05) at 3.5 hrs post-quit, while symptoms of ‘depression’ manifested 
significantly (p<0.05) only at 18hrs post-smoking cessation. Symptoms of ‘anxiety’ peaked at 
18hrs of abstinence. Brown et al. (2013) assessed the time course of mood symptoms by testing 
smokers randomized to receive a placebo treatment during temporary abstinence in a naturalistic 
setting (a train journey). Their findings revealed that symptoms of ‘irritability’ and ‘anxiety’ 
manifested significantly (p<0.05) at 3hrs post-smoking cessation. The severity of these symptoms 
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increased modestly over a 6 hrs time period. Symptoms of ‘depression’ showed a slower increase 
in comparison to symptoms of ‘anxiety’ and ‘irritability’. Smith et al. (2008) revealed that 50 
adolescent smokers (mean age=16.4 yrs) with a moderate level of tobacco dependence 
experienced a slight increase in ‘anger’ during an acute tobacco abstinence period ranging from 
1hr to 24hrs. 
Bujarski et al. (2015) revealed that composite ‘NA’ symptoms manifested significantly (p<0.05) 
at 3hrs post-smoking cessation in 30 daily smokers and peaked at 24hrs of abstinence. Similarly, 
the studies conducted by Sheets et al. (2015) and by Aguirre et al. (2015), showed that symptoms 
of composite ‘NA’ started at 1hr post-quit, steadily increasing until their latest mood 
measurements performed at 24hrs (Sheets et al., 2015), and at 17hrs (Aguirre et al., 2015). 
Besides reporting changes on mood and anxiety symptoms at different time points, the studies 
conducted by Aguirre et al. (2015), Bujarski et al. (2015), and by Sheets et al. (2015) also 
assessed the interaction between severity of tobacco dependence and hours of tobacco abstinence. 
Specifically, the study conducted by Aguirre et al. (2015) revealed that levels of tobacco 
dependence (as reported by the FTND) predicted significantly (p<0.001) composite ‘NA’. 
Additionally, Bujarski et al. (2015) showed a difference in relation to the progression of ‘NA’ 
symptoms between moderate and heavy smokers in the earliest phases of withdrawal as “post-hoc 
tests revealed significant group (p<0.05) difference beginning 3 hours after the last cigarette such 
that heavy smokers had significantly (p<0.05) greater withdrawal/NA as compared to moderate 
smokers starting 3 hours after the last cigarette and lasting until the end of the day”(72, p.1). 
Likewise, Sheets et al. (2015) revealed that heavy smokers experienced worse negative emotions 
compared to light smokers during an acute abstinence period ranging from 1hr to24 hrs. 
In summary, these findings suggest that negative mood and anxiety symptoms emerge within the 
first 3 hours post-smoking cessation, and that the severity of these symptoms increase steadily 
over a 24hrs period of abstinence without receiving any form of treatment. This seems to be 
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especially relevant for ‘anxiety’ and ‘anger/irritability’. Furthermore, smokers with severe tobacco 
dependence seem to experience worse mood symptoms. These results provide further support to 






The current review was conducted to 1) provide a quantification of the severity of negative mood 
and anxiety symptoms occurring up to 24hrs during acute tobacco abstinence, 2) to investigate 
possible sex differences related to the experience of specific symptoms, and 3) to investigate the 
early time course of symptoms. 
Results from quantitative analyses revealed a significant (p<0.0001) increase in ‘anxiety’, 
‘anger/irritability’, ‘depressed mood /sadness’, and a significant increase in composite ‘NA’ 
(p=0.015) within a mean time period of 17hrs (SD=3.63) post-smoking cessation. These findings 
provide support to the DSM-V guidelines related to the ‘Tobacco Withdrawal Syndrome’ and to a 
previous review conducted by McLaughlin, Dani, & De Biasi (2015) that proposed the emergence 
of an aversive tobacco abstinence syndrome at 4hrs-24hrs post-quit. 
Uniquely, this review proposes ‘anxiety’ as the most severe affective symptom (SDM=0.63) 
experienced by daily smokers during the acute abstinence period, followed by ‘anger/irritability’ 
(SDM=0.51). Results from the qualitative analysis suggest that these symptoms may emerge as 
early as 3hrs post-smoking cessation and increase steadily in the following hours. These findings 
are in contrast to previous studies showing affective symptoms to not peak significantly below 
than 24 hrs post abstinence (Hatsukami et al, 1989). Symptoms of depressed mood are milder 
(SDM=0.27) and appear late compared to symptoms of anxiety and irritability, thus supporting 
the findings of another review (Hughes, 2007b) in which depression and dysphoric mood 





Results from both quantitative and qualitative analyses confirm that female smokers suffer more 
severe mood and anxiety symptoms during an acute abstinence period compared to male smokers, 
thus endorsing the strong impact of sex in the experience of negative affect during acute 
abstinence from tobacco. This finding is in line with a literature review conducted recently by 
Becker et al (2017). According to these authors, sex and gender differences occur in all stages of 
the drug addiction cycle. Specific to the abstinence phase, there is evidence from the literature that 
women suffer more severe negative affect compared to men. This occurs with the majorities of 
drugs of abuse, including tobacco. Becker and colleagues (2017) provided a comprehensive 
explanation of the possible physiological causes of this phenomenon, revealing that the menstrual 
cycle and the production of ovarian hormones may exacerbate the subjective effects of drug intake 
and abstinence in women. 
The current review also proposes a relationship between the severity of tobacco dependence and 
the experience of mood and anxiety symptoms during acute tobacco abstinence for daily smokers. 
In particular, meta-regression results revealed that levels of tobacco dependence may predict 
significantly (p<0.0001) the emergence of mood and anxiety symptoms in the hours following 
smoking cessation. Additionally, ‘anxiety’, ‘anger/irritability’, ‘depressed mood’, and composite 
‘NA’ symptoms were found to be more severe for daily smokers reporting a high level of tobacco 
dependence compared to daily smokers reporting a medium or low level of tobacco dependence as 
revealed by our subgroup analyses (see section 3.1). 
This relationship could be explained through the allostasis theory of Koob (2001). According to 
Koob and Le Moal (2005), the affective and motivational changes experienced during acute drug 
abstinence are related to a neurobiological opponent-process mechanism within the brain’s reward 
circuitry that is dysregulated by chronic drug intake. In particular, “as dependence and withdrawal 
episodes occur, the brain anti- reward systems including corticotropin releasing factor (CRF), 
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norepinephrine and dynorphin are recruited. These neurotransmitter systems are activated during 
the development of excessive drug taking, and this activation is manifest when the drug in 
removed” (Koob & LeMoal,2005, p.1). The recruitment of these anti-reward systems in 
combination with decreases in reward-linked neurotransmitter function is thought to cause the 
emergence of negative affective states during drug abstinence, which in turn may motivate lapse 
or relapse (i.e. negative reinforcement) (Koob & Le Moal, 2005). A review conducted by Hughes 
(2007a) provided further support to this statement by revealing ‘anxiety’, ‘anger/irritability’, and 
‘depressed mood’ to be true, time limited tobacco abstinence effects and not “offset effects”. 
4.1 Strengths and limitations 
 
The current review has a number of strengths such as the stringent database search methodology 
encompassing keywords from both DSM-V and the RDoC matrix. The utilization of the RDoC 
matrix allowed the inclusion of relevant units of analysis as alternative search terms to the main 
mood symptoms listed in DSM-V. Additionally, the inclusion/exclusion criteria were rigorous, 
thus enabling the exclusion of confounders such as daily smokers affected by psychiatric 
disorders, dependency on other drugs, or subjects enrolled in smoking cessation 
treatment/programs. Furthermore, only samples of smokers receiving a placebo treatment or no 
treatment at all were included in the quantitative and qualitative syntheses. Samples of smokers 
receiving any form of treatment (e.g. NRTs, counselling) were not included in the current review, 
thus allowing the assessment of mood symptoms that daily smokers are likely to suffer during 
unassisted quit attempts. This is important considering that majority of smokers attempt to quit 
without utilizing any form of treatment or medication (Edwards et al., 2014; Smith et al., 2015). 
Methodological strengths encompass the exclusion of studies employing a between-subjects 
experimental design only (e.g. smokers vs nonsmokers) from the current review. Notably, they 
present greater between-subjects variability (Shiffman, West, & Gilbert, 2004) and lower internal 
validity compared to studies employing a within-subjects experimental design (Hughes et al., 
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2018). Studies employing a within-subjects design are considered optimal to test the effect of 
tobacco abstinence on withdrawal symptoms (Shiffman, West, & Gilbert, 2004). Additionally, 
only within-group measurements were extracted from studies employing a mixed method within- 
subjects and between-subjects experimental design. 
The concurrent investigation of relevant moderator variables such as ‘sex’, ‘severity of 
dependence’, and ‘hours of abstinence’ on the experience of negative mood symptoms emerging 
during acute tobacco abstinence could be considered another strength of the current review. In 
particular, the utilization of both quantitative and qualitative analysis techniques allowed to 
validate the impact of ‘sex’, and ‘hours of abstinence’ on specific mood symptoms. The insertion 
of other moderator variables such as ‘years of smoking’, and ‘cigarettes smoked per day’ was 
taken in consideration, although a study conducted by Donny et al. (2008) revealed that ‘cigarette 
smoked per day’ and ‘years of smoking’ accounted for just <6% of the variance in the severity of 
tobacco dependence in 489 daily smokers. Thus, scales of tobacco and nicotine dependence with 
high internal validity and reliability such as The Fagerström Test for Nicotine Dependence 
(‘FTND’) (Heaterton et al., 1991) may constitute a more appropriate moderator and were 
therefore utilized to compute the ‘severity of dependence’ covariate. 
The current review also presents several potential limitations. In particular, it was not possible to 
investigate thoroughly the ‘age’ moderator variable as only a few studies tested adolescent daily 
smokers (Bidwell et al., 2013; Colby et al, 2010; Everson et al, 2006; Smith et al. 2009). As 
introduced previously, it has been proposed that adolescent smokers may experience less severe 
withdrawal symptoms during abstinence in comparison to adult smokers (Lydon et al., 2014). 
Furthermore, it has been proposed that smokers with the intention to quit for good may suffer 
more severe withdrawal symptoms in comparison to smokers with no intention to quit (Perkins, 
Stitzer, & Lerman, 2006). Only one study of those included in the review tested smokers who 
intended to quit (West & Hajek, 2004), thus it was not possible to include ‘intention to quit’ as a 
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moderator in both quantitative and qualitative analyses. Consequently, the magnitude of 
abstinence effects on mood symptoms revealed by the current review could be underestimated. 
Another potential limitation could be related to the CO cut-off values necessary to distinguish 
smokers from nonsmokers within 24hrs of acute abstinence used by the studies included in the 
review. In fact, while the majority of studies (75%) who reported CO values used a cut-off 
criteria of 8-10ppm as described by the SRNT subcommittee on Biochemical Verification 
(2002), a study conducted by Cropsey et al. (2014) revealed that this cut-off value may be too 
high and may produce high false-negative rates (up to 20%). Thus, several smoking 
participants could have been misclassified as abstinent by the studies included in the review. 
The inability to test the impact of acute tobacco abstinence on ‘Anhedonia’, which has been 
recently proposed as a novel affective symptom of the tobacco withdrawal syndrome (Hughes et 
al, 2018), could be considered another limitation of the current review. The relationship between 
negative affective symptoms and craving, which has a significant impact on smoking lapse and 
relapse, was also not investigated as it was beyond the scope of this study. Additionally, this 
review did not explore racial/ethnic differences in mood and anxiety symptoms emerging during 
acute abstinence from tobacco. In fact, recent studies proposed differences related to the 
experience of withdrawal symptoms and smoking cessation outcomes across different 
racial/ethnic groups (e.g. Weinberger et al., 2017; Bello et al., 2015). 
Finally, the current review focused on tobacco smoking, excluding investigation of aversive mood 
symptoms occurring during the first few hours of abstinence from alternative methods of nicotine 








4.2 Clinical Relevance 
 
The clinical relevance of the current review resides in the quantification of the severity of 
negative mood and anxiety symptoms occurring during acute abstinence from tobacco, in addition 
to sex differences and to their early time course. In particular, a strong relationship between sex 
and the severity of negative mood and anxiety symptoms experienced during acute tobacco 
abstinence should motivate researchers and clinicians to identify and provide sex- tailored 
interventions targeting relevant negative mood symptoms. This would be of importance 
considering the strong association between negative affective symptoms and lapses/relapses (e.g. 
Ferguson et al., 2017; Minami et al., 2014; Patterson et al., 2008), and that women who lapse 
early exhibit heightened negative mood symptoms immediately after quitting (Cofta-Woerpel et 
al., 2011). Furthermore, a recent review conducted by Smith et al. (2016), that explored sex 
variations in smoking cessation, revealed that women have more difficulty maintaining long-term 
abstinence and relapse more frequently compared to men (Smith et al., 2016). 
Smoking cessation treatments should also consider the severity of specific mood 
symptoms experienced by smokers with different levels of tobacco dependence during 
acute abstinence, in addition to their early manifestation and time course. This could be 
done by providing targeted mood related counselling and/or medications to alleviate the 
distress of daily smokers as soon as they quit. This would allow a timely and effective 
targeting of symptoms such as ‘anxiety’ and ‘anger/irritability’, which appear to manifest 
and to peak earlier in comparison to symptoms of ‘depressed mood/sadness’. A timely 
targeting of negative mood symptoms would prevent smoking reinstatement as early 
lapses may occur few hours following smoking cessation (Bolman et al., 2018; Brown et 
al., 2005; Deiches et al., 2013 ; Franklin et al.,2018; ).Additionally, a recent study 
conducted by Zuo, Rabinovich, and Gilbert (2017) revealed that “slower dissipation of 
negative affect, especially anxiety and anger, represents a greater risk for relapse to 
smoking beyond that predicted by craving during early abstinence. Thus, temporal 
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profiles of the affective symptoms convey unique motivational significance in relapse. 
Reduction in NA during early abstinence may be a valid target for interventions to 
increase long-term cessation success rates” (p.761). 
The current review has also underlined the utility of subjective scales of tobacco dependence (e.g. 
FTND). In particular, considering the possible relationship between scores on scales of tobacco 
dependence and the severity of mood and anxiety symptoms experienced by daily smokers during 
acute abstinence, these could be used by healthcare providers to predict the intensity of negative 




The current review has quantified the severity of mood and anxiety symptoms emerging during 
acute tobacco abstinence by revealing a significant increase (p<0.0001) in ‘anxiety’, 
‘anger/irritability’, and ‘depressed mood/sadness’ within 24 hours following smoking cessation. It 
showed ‘anxiety’ to be the most severe symptom (SDM=0.63) experienced by daily smokers 
during acute abstinence, and ‘depressed mood/sadness’ to be the mildest symptom (SDM=0.27). 
Additionally, this review confirmed that female smokers suffer worse mood and anxiety 
symptoms in comparison to male smokers during acute tobacco abstinence. These symptoms 
manifest within 3hrs post-quit and increase steadily over a 24hrs period. 
Considering the strong impact of acute tobacco abstinence on mood and anxiety symptoms and 
their early manifestation, future research should focus on investigating the severity and time- 
course of the same symptoms occurring during acute abstinence from alternative methods of 
nicotine administration such as vaporizers and e-cigarettes, which remain under-investigated. 
Furthermore, considering that the current review included only four studies testing adolescent 
daily smokers, and that there is a lack of summarized empirical evidence in the literature, future 
reviews and meta-analyses should explore the impact of acute abstinence on mood symptoms in 
smokers from younger age groups. This would be of importance considering that tobacco 
addiction is mainly established in adolescence due to the vulnerability of adolescents’ brain. 
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Finally, the current review has underlined the importance of implementing sex-tailored 
interventions targeting mood symptoms in smoking cessation programs. These might reduce 




Conflicts of Interest 
 
There are no possible conflicts of interest arising. A.A.C and S.T. reports no financial 
relationships with commercial interests. J.D.S receives Medical Research Council (MRC) 
Programme Grant funding and has received indirect funding from a Wellcome Trust Strategic 
Award. A.B. has received research project funding from the MRC, Chief Scientist Office 






There was no financial support to assist with the analysis and preparation of this manuscript. 
 





Aguirre, C. G., Madrid, J., & Leventhal, A. M. (2015). Tobacco withdrawal symptoms mediate 
motivation to reinstate smoking during abstinence. J. Abnorm. Psychol., 124(3), 623. 
https://psycnet.apa.org/doi/10.1037/abn0000060 
al'Absi, M., Amunrud, T., & Wittmers, L. E. (2002). Psychophysiological effects of nicotine 
abstinence and behavioral challenges in habitual smokers. Pharmacol. Biochem. Behav., 
72(3), 707-716. https://doi.org/10.1016/S0091-3057(02)00739-6 
Allen, S. S., Bade, T., Hatsukami, D., & Center, B. (2008). Craving, withdrawal, and smoking 
urges on days immediately prior to smoking relapse. Nicotine Tob. Res., 10(1), 35-45. 
https://doi.org/10.1080/14622200701705076 
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders 
(4th ed.). 
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders 
(5th ed.). https://doi.org/10.1176/appi.books.9780890425596 
Ashare, R. L., & Kable, J. W. (2015). Sex differences in time perception during smoking 
abstinence. Nicotine Tob. Res., 17(4), 449-454. https://doi.org/10.1093/ntr/ntu260 
Babb, S. (2017). Quitting smoking among adults—United States, 2000–2015. MMWR. 
Morbidity and mortality weekly report, 65. http://dx.doi.org/10.15585/mmwr.mm6552a1 
Baker, T. B., Piper, M. E., McCarthy, D. E., Majeskie, M. R., & Fiore, M. C. (2004). Addiction 
motivation reformulated: an affective processing model of negative reinforcement. 
Psychol. Rev., 111(1), 33. doi: 10.1037/0033-295X.111.1.33 
Balk, E. M., Earley, A., Patel, K., Trikalinos, T. A., & Dahabreh, I. J. (2012). Empirical 
assessment of within-arm correlation imputation in trials of continuous outcomes. 
Available from: https://www.ncbi.nlm.nih.gov/books/NBK115797/ 
Becker, J. B., McClellan, M. L., & Reed, B. G. (2017). Sex differences, gender and addiction. 
J.Neurosci. Res., 95(1-2), 136-147. https://doi.org/10.1002/jnr.23963 
Bello, M. S., Pang, R. D., Cropsey, K. L., Zvolensky, M. J., Reitzel, L. R., Huh, J., & Leventhal, 
A. M. (2015). Tobacco withdrawal amongst African American, Hispanic, and white 
smokers. Nicotine Tob. Res., 18(6), 1479-1487. https://doi.org/10.1093/ntr/ntv231 
Bidwell, L. C., Leventhal, A. M., Tidey, J. W., Brazil, L., Niaura, R. S., & Colby, S. M. (2012). 
Effects of abstinence in adolescent tobacco smokers: Withdrawal symptoms, urge, affect, 
and cue reactivity. Nicotine Tob. Res., 15(2), 457-464. https://doi.org/10.1093/ntr/nts155 
Bolman, C., Verboon, P., Thewissen, V., Boonen, V., Soons, K., & Jacobs, N. (2018). Predicting 
smoking lapses in the first week of quitting: an ecological momentary assessment study. 
J. Addict. Med., 12(1), 65.doi:10.1097/ADM.0000000000000365 
Borenstein, M., Cooper, H., Hedges, L., & Valentine, J. (2009). Effect sizes for continuous data. 
The handbook of research synthesis and meta-analysis, 2, 221-235. 
Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. Comprehensive Meta-Analysis Version 3 
Biostat, Englewood, NJ 2013. 
Borrelli, B., Spring, B., Niaura, R., Hitsman, B., & Papandonatos, G. (2001). Influences of 
gender and weight gain on short-term relapse to smoking in a cessation trial. J Consult 
Clin. Psychol, 69(3), 511. https://psycnet.apa.org/doi/10.1037/0022-006X.69.3.511 
Brown, J., Hajek, P., McRobbie, H., Locker, J., Gillison, F., McEwen, A., ... & West, R. (2013). 
Cigarette craving and withdrawal symptoms during temporary abstinence and the effect 
of nicotine gum. Psychopharmacol., 229(1), 209-218. https://doi.org/10.1007/s00213- 
013-3100-2 
Brown, R. A., Lejuez, C. W., Kahler, C. W., Strong, D. R., & Zvolensky, M. J. (2005). Distress 
tolerance and early smoking lapse. Clin. Psychol. Rev., 25(6), 713-733. 
https://doi.org/10.1016/j.cpr.2005.05.003 
Bujarski, S., Roche, D. J., Sheets, E. S., Krull, J. L., Guzman, I., & Ray, L. A. (2015). Modeling 
naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot 
41 
 
ecological momentary assessment study. Exp. Clin. Psychopharmacol., 23(2), 81. 
https://psycnet.apa.org/doi/10.1037/a0038861 
Castro, Y., Kendzor, D. E., Businelle, M. S., Mazas, C. A., Cofta-Woerpel, L., Cinciripini, P. M., 
& Wetter, D. W. (2011). Structural and predictive equivalency of the Wisconsin 
Smoking Withdrawal Scale across three racial/ethnic groups. Nicotine Tob Res, 13(7), 
548-555. https://doi.org/10.1093/ntr/ntr039 
Chaiton, M. O., Cohen, J. E., O'Loughlin, J., & Rehm, J. (2009). A systematic review of 
longitudinal studies on the association between depression and smoking in adolescents. 
BMC public health, 9(1), 356. https://doi.org/10.1186/1471-2458-9-356 
Chaiton, M., Diemert, L., Cohen, J. E., Bondy, S. J., Selby, P., Philipneri, A., & Schwartz, R. 
(2016). Estimating the number of quit attempts it takes to quit smoking successfully in a 
longitudinal cohort of smokers. BMJ open, 6(6), e011045. doi: 10.1136/bmjopen-2016- 
011045. 
Cofta-Woerpel, L., McClure, J. B., Li, Y., Urbauer, D., Cinciripini, P. M., & Wetter, D. W. 
(2011). Early cessation success or failure among women attempting to quit smoking: 
Trajectories and volatility of urge and negative mood during the first postcessation week. 
J.Abnorm. Psychol., 120(3), 596. https://psycnet.apa.org/doi/10.1037/a0023755 
Cohen J. 1988. Statistical power analysis for the social sciences. 
Colby, S. M., Leventhal, A. M., Brazil, L., Lewis-Esquerre, J., Stein, L. A. R., Rohsenow, D. J., 
... & Niaura, R. S. (2009). Smoking abstinence and reinstatement effects in adolescent 
cigarette smokers. Nicotine Tob. Res., 12(1), 19-28. https://doi.org/10.1093/ntr/ntp167 
Cook, J. W., Spring, B., McChargue, D., & Hedeker, D. (2004). Hedonic capacity, cigarette 
craving, and diminished positive mood. Nicotine Tob. Res., 6(1), 39-47. 
https://doi.org/10.1080/14622200310001656849 
Craig, D., Parrott, A., & Coomber, J. A. (1992). Smoking cessation in women: Effects of the 
menstrual cycle. Int J Addict, 27(6), 697-706. 
https://doi.org/10.3109/10826089209068761 
Cropsey, K. L., Trent, L. R., Clark, C. B., Stevens, E. N., Lahti, A. C., & Hendricks, P. S. (2014). 
How low should you go? Determining the optimal cutoff for exhaled carbon monoxide 
to confirm smoking abstinence when using cotinine as reference. Nicotine Tob Res, 
16(10), 1348-1355. https://doi.org/10.1093/ntr/ntu085 
Deiches, J. F., Baker, T. B., Lanza, S., & Piper, M. E. (2013). Early lapses in a cessation attempt: 
lapse contexts, cessation success, and predictors of early lapse. Nicotine Tob. Res., 
15(11), 1883-1891. https://doi.org/10.1093/ntr/ntt074 
Dixon-Woods, M., Agarwal, S., Jones, D., Young, B., & Sutton, A. (2005). Synthesising 
qualitative and quantitative evidence: a review of possible methods. Journal of health 
services research & policy, 10(1), 45-53. 
https://doi.org/10.1177%2F135581960501000110 
Doherty, K., Kinnunen, T., Militello, F. S., & Garvey, A. J. (1995). Urges to smoke during the 
first month of abstinence: relationship to relapse and predictors. Psychopharmacol., 
119(2), 171-178. https://doi.org/10.1007/BF02246158 
Donny, E. C., Griffin, K. M., Shiffman, S., & Sayette, M. A. (2008). The relationship between 
cigarette use, nicotine dependence, and craving in laboratory volunteers. Nicotine Tob. 
Res., 10(3), 447-455. https://doi.org/10.1080/14622200801901906 
Edwards, S. A., Bondy, S. J., Callaghan, R. C., & Mann, R. E. (2014). Prevalence of unassisted 
quit attempts in population-based studies: a systematic review of the literature. Addictive 
Behaviors, 39(3), 512-519. https://doi.org/10.1016/j.addbeh.2013.10.036 
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a 
simple, graphical test. Bmj, 315(7109), 629-634. 
https://doi.org/10.1136/bmj.315.7109.629 
Etter, J. F., Prokhorov, A. V., & Perneger, T. V. (2002). Gender differences in the psychological 
determinants of cigarette smoking. Addiction, 97(6), 733-743. 
https://doi.org/10.1046/j.1360-0443.2002.00135.x 
Everson, E. S., Daley, A. J., & Ussher, M. (2006). Does exercise have an acute effect on desire to 
smoke, mood and withdrawal symptoms in abstaining adolescent smokers?. 
42 
 
Addict.Behav., 31(9), 1547-1558. https://doi.org/10.1016/j.addbeh.2005.11.007 
Ferguson, S. G., Shiffman, S., & Blizzard, L. (2017). Triggers of smoking lapses over the course 
of a quit attempt. J.Smoking Cessat., 12(4), 205-212. https://doi.org/10.1017/jsc.2016.21 
Fluharty, M., Taylor, A. E., Grabski, M., & Munafò, M. R. (2016). The association of cigarette 
smoking with depression and anxiety: a systematic review. Nicotine Tob. Res., 19(1), 3- 
13. https://doi.org/10.1093/ntr/ntw140 
Follmann, D., Elliott, P., Suh, I. L., & Cutler, J. (1992). Variance imputation for overviews of 
clinical trials with continuous response. J. Clin. Epidemiol., 45(7), 769-773. 
https://doi.org/10.1016/0895-4356(92)90054-Q 
Franklin, T. R., Jagannathan, K., Hager, N., Fang, Z., Xu, S., Wong, J., ... & Wetherill, R. (2018). 
Brain substrates of early (4 h) cigarette abstinence: Identification of treatment targets. 
Drug Alcohol Depend., 182, 78-85. https://doi.org/10.1016/j.drugalcdep.2017.10.010 
Froeliger, B., McConnell, P. A., Stankeviciute, N., McClure, E. A., Kalivas, P. W., & Gray, K. 
M. (2015). The effects of N-acetylcysteine on frontostriatal resting-state functional 
connectivity, withdrawal symptoms and smoking abstinence: a double-blind, placebo- 
controlled fMRI pilot study. Drug Alcohol Depend., 156, 234-242. 
https://doi.org/10.1016/j.drugalcdep.2015.09.021 
Fu, R., Vandermeer, B. W., Shamliyan, T. A., O’Neil, M. E., Yazdi, F., Fox, S. H., & Morton, S. 
C. (2013). Handling continuous outcomes in quantitative synthesis. In Methods Guide for 
Effectiveness and Comparative Effectiveness Reviews [Internet]. Agency for Healthcare 
Research and Quality (US). 
Hall, F. S., Der-Avakian, A., Gould, T. J., Markou, A., Shoaib, M., & Young, J. W. (2015). 
Negative affective states and cognitive impairments in nicotine dependence. 
Neurosci.Biobehav. Rev., 58, 168-185. https://doi.org/10.1016/j.neubiorev.2015.06.004 
Hatsukami, D., Fletcher, L., Morgan, S., Keenan, R., & Amble, P. P. (1989). The effects of 
varying cigarette deprivation duration on cognitive and performance tasks. J. Subst. 
Abuse. https://psycnet.apa.org/record/1997-73134-001 
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & FAGERSTROM, K. O. (1991). The 
Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance 
Questionnaire. Brit J Addict., 86(9), 1119-1127. https://doi.org/10.1111/j.1360- 
0443.1991.tb01879.x 
Heffner, J. L., Mingione, C., Blom, T. J., & Anthenelli, R. M. (2011). Smoking history, nicotine 
dependence, and changes in craving and mood during short-term smoking abstinence in 
alcohol dependent vs. control smokers. Addict Behav, 36(3), 244-247. 
https://doi.org/10.1016/j.addbeh.2010.10.008 
Hendricks, P. S., & Leventhal, A. M. (2013). Abstinence-related expectancies predict smoking 
withdrawal effects: Implications for possible causal mechanisms. Psychopharmacol., 
230(3), 363-373. https://doi.org/10.1007/s00213-013-3169-7 
Hendricks, P. S., Ditre, J. W., Drobes, D. J., & Brandon, T. H. (2006). The early time course of 
smoking withdrawal effects. Psychopharmacol., 187(3), 385-396. 
https://doi.org/10.1007/s00213-006-0429-9 
Higgins, J. P., & Green, S. (Eds.). (2011). Cochrane handbook for systematic reviews of 
interventions (Vol. 4). John Wiley & Sons. 
Hughes, J. R. (2007a). Effects of abstinence from tobacco: valid symptoms and time course. 
Nicotine Tob. Res., 9(3), 315-327. https://doi.org/10.1080/14622200701188919 
Hughes, J. R. (2007b). Effects of abstinence from tobacco: etiology, animal models, 
epidemiology, and significance: a subjective review. Nicotine Tob. Res., 9(3), 329-339. 
https://doi.org/10.1080/14622200701188927 
Hughes, J. R., Keely, J., & Naud, S. (2004). Shape of the relapse curve and long‐term abstinence 
among untreated smokers. Addiction, 99(1), 29-38. https://doi.org/10.1111/j.1360- 
0443.2004.00540.x 
Hughes, J. R., Klemperer, E. M., & Peasley-Miklus, C. (2018). Possible New Symptoms of 
Tobacco Withdrawal II: Anhedonia—A Systematic Review. Nicotine Tob. Res. 
https://doi.org/10.1093/ntr/nty171 
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., ... & Wang, P. (2010). 
43 
 
Research domain criteria (RDoC): toward a new classification framework for research on 
mental disorders. https://doi.org/10.1176/appi.ajp.2010.09091379 
Jacobsen, L. K., Krystal, J. H., Mencl, W. E., Westerveld, M., Frost, S. J., & Pugh, K. R. (2005). 
Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. 
Biol. Psych., 57(1), 56-66. https://doi.org/10.1016/j.biopsych.2004.10.022 
Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. 
Neuropsychopharmacology, 24(2), 97. https://doi.org/10.1016/S0893-133X(00)00195-0 
Koob, G. F., & Le Moal, M. (2005). Plasticity of reward neurocircuitry and the'dark side'of drug 
addiction. Nat Neurosci, 8(11), 1442. https://doi.org/10.1038/nn1105-1442 
Lembke, A., Johnson, K., & DeBattista, C. (2007). Depression and smoking cessation: does the 
evidence support psychiatric practice?.Neuropsychiatr. Dis. Treat., 3(4), 487. 
Leventhal, A. M., Ameringer, K. J., Osborn, E., Zvolensky, M. J., & Langdon, K. J. (2013). 
Anxiety and depressive symptoms and affective patterns of tobacco withdrawal. Drug 
Alcohol Depend., 133(2), 324-329. 
Leventhal, A. M., Trujillo, M., Ameringer, K. J., Tidey, J. W., Sussman, S., & Kahler, C. W. 
(2014). Anhedonia and the relative reward value of drug and nondrug reinforcers in 
cigarette smokers. J. Abnorm. Psychol., 123(2), 375. 
https://psycnet.apa.org/doi/10.1037/a0036384 
Leventhal, A. M., Waters, A. J., Boyd, S., Moolchan, E. T., Lerman, C., & Pickworth, W. B. 
(2007). Gender differences in acute tobacco withdrawal: Effects on subjective, cognitive, 
and physiological measures. Exp. Clin. Psychopharm., 15(1), 21. 
https://psycnet.apa.org/doi/10.1037/1064-1297.15.1.21 
Leventhal, A. M., Waters, A. J., Moolchan, E. T., Heishman, S. J., & Pickworth, W. B. (2010). A 
quantitative analysis of subjective, cognitive, and physiological manifestations of the 
acute tobacco abstinence syndrome. Addict. Behav., 35(12), 1120-1130. 
https://doi.org/10.1016/j.addbeh.2010.08.007 
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P., ... & 
Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta- 
analyses of studies that evaluate health care interventions: explanation and elaboration. 
PLoS med., 6(7), e1000100. https://doi.org/10.1371/journal.pmed.1000100 
Lydon, D. M., Wilson, S. J., Child, A., & Geier, C. F. (2014). Adolescent brain maturation and 
smoking: what we know and where we’re headed. Neurosci. Biobehav. Rev., 45, 323- 
342. https://doi.org/10.1016/j.neubiorev.2014.07.003 
McLaughlin, I., Dani, J. A., & De Biasi, M. (2015). Nicotine withdrawal. In The 
Neuropharmacology of Nicotine Dependence (pp. 99-123). Springer, Cham. 
https://doi.org/10.1007/978-3-319-13482-6_4 
McNair, D. M., Lorr, M., & Droppleman, L. F. (1971). Manual for the profile of mood states 
(POMS). San Diego: Educational and Industrial Testing Service. 
McNair, D. M., Lorr, M., & Droppleman, L. (1981). Profile of mood states questionnaire. 
EDITS, San Diego, CA. 
Miech, R., Johnston, L., O’Malley, P. M., Bachman, J. G., & Patrick, M. E. (2019). Trends in 
Adolescent Vaping, 2017–2019. 381(15), 1490-1491. doi:10.1056/NEJMc1910739 
Minami, H., Yeh, V. M., Bold, K. W., Chapman, G. B., & McCarthy, D. E. (2014). Relations 
among affect, abstinence motivation and confidence, and daily smoking lapse risk. 
Psychol. Addict. Behav., 28(2), 376. https://psycnet.apa.org/doi/10.1037/a0034445 
Morrell, H. E., Cohen, L. M., & Al'Absi, M. (2008). Physiological and psychological symptoms 
and predictors in early nicotine withdrawal. Pharmacol. Biochem. Behav. 89(3), 272-278. 
https://doi.org/10.1016/j.pbb.2007.12.020 
Murray, R. P., Johnston, J. J., Dolce, J. J., Lee, W. W., & O'Hara, P. (1995). Social support for 
smoking cessation and abstinence: The Lung Health Study. Addict Behav, 20(2), 159-
170. https://doi.org/10.1016/S0306-4603(99)80001-X 
Pang, R. D., & Leventhal, A. M. (2013). Sex differences in negative affect and lapse behavior 
during acute tobacco abstinence: A laboratory study. Exp. Clin. Psychopharmacol., 21(4), 
269. https://psycnet.apa.org/doi/10.1037/a0033429 
Park, A. D., Farrahi, L. N., Pang, R. D., Guillot, C. R., Aguirre, C. G., & Leventhal, A. M. 
44 
 
(2016). Negative urgency is associated with heightened negative affect and urge during 
tobacco abstinence in regular smokers. J. Sud Alcohol Drugs,77(5), 766-773. 
https://doi.org/10.15288/jsad.2016.77.766 
Patterson, F., Kerrin, K., Wileyto, E. P., & Lerman, C. (2008). Increase in anger symptoms after 
smoking cessation predicts relapse. Drug Alcohol Depend, 95(1-2), 173-176. 
https://doi.org/10.1016/j.drugalcdep.2008.01.013 
Perkins, K. A., Karelitz, J. L., Giedgowd, G. E., & Conklin, C. A. (2013). Negative mood effects 
on craving to smoke in women versus men. Addict. Behav., 38(2), 1527-1531. 
https://doi.org/10.1016/j.addbeh.2012.06.002 
Perkins, K. A., Stitzer, M., & Lerman, C. (2006). Medication screening for smoking cessation: a 
proposal for new methodologies. Psychopharmacol., 184(3-4), 628-636. 
https://doi.org/10.1007/s00213-005-0105-5 
Piper, M. E., & Curtin, J. J. (2006). Tobacco withdrawal and negative affect: An analysis of 
initial emotional response intensity and voluntary emotion regulation. J. Abnorm. 
Psychol., 115(1), 96. doi:10.1037/0021-843X.115.1.96 
Piper, M. E., Bullen, C., Krishnan-Sarin, S., Rigotti, N. A., Steinberg, M. L., Streck, J. M., & 
Joseph, A. M. (2019). Defining and measuring abstinence in clinical trials of smoking 
cessation interventions: An updated review. Nicotine & Tob Res. 
https://doi.org/10.1093/ntr/ntz110 
Piper, M. E., Schlam, T. R., Cook, J. W., Sheffer, M. A., Smith, S. S., Loh, W. Y., ... & Baker, T. 
B. (2011). Tobacco withdrawal components and their relations with cessation success. 
Psychopharmacol., 216(4), 569-578. https://doi.org/10.1007/s00213-011-2250-3 
Poulos, C. X., & Cappell, H. (1991). Homeostatic theory of drug tolerance: a general model of 
physiological adaptation. Psychol rev, 98(3), 390. 
https://psycnet.apa.org/doi/10.1037/0033-295X.98.3.390 
Quinn, A., Sekimura, S., Pang, R., Trujillo, M., Kahler, C. W., & Leventhal, A. M. (2013). 
Hostility as a predictor of affective changes during acute tobacco withdrawal. Nicotine 
Tob. Res., 16(3), 335-342. https://doi.org/10.1093/ntr/ntt151. 
Rosenthal, R. (1979). The file drawer problem and tolerance for null results. Psychol. bulletin, 
86(3), 638. https://psycnet.apa.org/doi/10.1037/0033-2909.86.3.638 
Rossi, V., & Pourtois, G. (2012). Transient state-dependent fluctuations in anxiety measured 
using STAI, POMS, PANAS or VAS: a comparative review. Anxiety, Stress & Coping, 
25(6), 603-645. https://doi.org/10.1080/10615806.2011.582948 
Sheets, E. S., Bujarski, S., Leventhal, A. M., & Ray, L. A. (2015). Emotion differentiation and 
intensity during acute tobacco abstinence: A comparison of heavy and light smokers. 
Addict. Behav., 47, 70-73. https://doi.org/10.1016/j.addbeh.2015.03.024 
Shiffman, S., West, R. J., & Gilbert, D. G. (2004). Recommendation for the assessment of 
tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob. Res., 6(4), 
599-614. https://doi.org/10.1080/14622200410001734067 
Simmonds, M. (2015). Quantifying the risk of error when interpreting funnel plots. Syst.Rev., 
4(1), 24. https://doi.org/10.1186/s13643-015-0004-8 
Smith, A. E., Cavallo, D. A., Dahl, T., Wu, R., George, T. P., & Krishnan-Sarin, S. (2008). 
Effects of acute tobacco abstinence in adolescent smokers compared with nonsmokers. 
J.Adol. Health, 43(1), 46-54. https://doi.org/10.1016/j.jadohealth.2007.12.004 
Smith, A. L., Carter, S. M., Dunlop, S. M., Freeman, B., & Chapman, S. (2015). The views and 
experiences of smokers who quit smoking unassisted. A systematic review of the 
qualitative evidence. PloS one, 10(5), e0127144. 
https://doi.org/10.1371/journal.pone.0127144 
Smith, P. H., Kasza, K. A., Hyland, A., Fong, G. T., Borland, R., Brady, K., ... & McKee, S. A. 
(2015). Gender differences in medication use and cigarette smoking cessation: results 
from the International Tobacco Control Four Country Survey. Nicotine Tob. Res., 
17(4), 463-472. https://doi.org/10.1093/ntr/ntu212 
Smith, P. H., Bessette, A. J., Weinberger, A. H., Sheffer, C. E., & McKee, S. A. (2016). 




Solomon, R. L., & Corbit, J. D. (1974). An opponent-process theory of motivation: I. Temporal 
dynamics of affect. Psychol rev, 81(2), 119. 
https://psycnet.apa.org/doi/10.1037/h0036128 
Solomon, R. L., & Corbit, J. D. (1974). An opponent-process theory of motivation: I. Temporal 
dynamics of affect. Psychol rev, 81(2), 119. 
https://psycnet.apa.org/doi/10.1037/h0036128 
SRNT Subcommittee on Biochemical Verification. (2002). Biochemical verification of tobacco 
use and cessation. Nicotine & Tobacco Research, 4(2), 149-159 
Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., ... & Thacker, 
S. B. (2000). Meta-analysis of observational studies in epidemiology: a proposal for 
reporting. Jama, 283(15), 2008-2012. doi:10.1001/jama.283.15.2008 
Study Quality Assessment Tools. National Heart, Lung, and Blood Institute website. 
https://www.nhlbi.nih.gov/health- topics/study-quality-assessment-tools 
Taylor, G., McNeill, A., & Aveyard, P. (2015). Does deterioration in mental health after smoking 
cessation predict relapse to smoking?. BMC pub. health, 15(1), 1150. 
https://doi.org/10.1186/s12889-015-2473-z 
Wang, T. W., Asman, K., Gentzke, A. S., Cullen, K. A., Holder-Hayes, E., Reyes-Guzman, C., ... 
& King, B. A. (2018). Tobacco product use among adults—United States, 
2017.Morbidity and Mortality Weekly Report, 67(44), 1225. doi: 
10.15585/mmwr.mm6744a2  
Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures 
of positive and negative affect: the PANAS scales. J Pers Soc Psychol, 54(6), 1063. 
http://dx.doi.org/10.1037/0022-3514.54.6.1063 
Weinberger, A. H., Kashan, R. S., Shpigel, D. M., Esan, H., Taha, F., Lee, C. J., ... & Goodwin, 
R. D. (2017). Depression and cigarette smoking behavior: a critical review of 
population-based studies. The American journal of drug and alcohol abuse, 43(4), 416-
431. https://doi.org/10.3109/00952990.2016.1171327 
Welsch SK, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Development and 
validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharm. 
1999;7:354–361. doi:10.1037/1064-1297.7.4.354. 
https://psycnet.apa.org/doi/10.1037/1064-1297.7.4.354 
West, R., & Hajek, P. (2004). Evaluation of the mood and physical symptoms scale (MPSS) 
toassess cigarette withdrawal. Psychopharmacol., 177(1-2), 195-199. 
https://doi.org/10.1007/s00213-004-1923-6 
West, R., Ussher, M., Evans, M., & Rashid, M. (2006). Assessing DSM-IV nicotine withdrawal 
symptoms: a comparison and evaluation of five different scales. Psychopharmacol, 
184(3-4), 619-627. https://doi.org/10.1007/s00213-005-0216-z 
Wong, J. A., Pickworth, W. B., Waters, A. J., al'Absi, M., & Leventhal, A. M. (2014). Cortisol 
levels decrease after acute tobacco abstinence in regular smokers. 
Hum.Psychopharma.Clin. , 29(2), 152-162. https://doi.org/10.1002/hup.2382 
World Health Organisation, Tobacco.https://www.who.int/news-room/fact-sheets/detail/tobacco. 
Accessed 3 September 2019 
Xu, J., Azizian, A., Monterosso, J., Domier, C. P., Brody, A. L., London, E. D., & Fong, T. W. 
(2008). Gender effects on mood and cigarette craving during early abstinence and 
resumption of smoking. Nicotine Tob. Res., 10(11), 1653-1661. 
https://doi.org/10.1080/14622200802412929 
Zelle, S. L., Gates, K. M., Fiez, J. A., Sayette, M. A., & Wilson, S. J. (2017). The first day is 
always the hardest: Functional connectivity during cue exposure and the ability to resist 
smoking in the initial hours of a quit attempt. NeuroImage, 151, 24-32. 
https://doi.org/10.1016/j.neuroimage.2016.03.015 
Zuo, Y., Rabinovich, N. E., & Gilbert, D. G. (2017). Negative affect subtypes and craving 
differentially predict long-term cessation success among smokers achieving initial 
abstinence. Psychopharmacol., 234(5), 761-771. https://doi.org/10.1007/s00213-016- 
4509-1 
                            
46 
 
           Zvolensky, M. J., Stewart, S. H., Vujanovic, A. A., Gavric, D., & Steeves, D. (2009). Anxiety 
sensitivity and anxiety and depressive symptoms in the prediction of early smoking 
lapse and relapse during smoking cessation treatment. Nicotine Tob. Res., 11(3), 323-
331. https://doi.org/10.1093/ntr/ntn037
 
 
 
